StockNews.com initiated coverage on shares of Kamada (NASDAQ:KMDA – Free Report) in a research note published on Thursday morning. The brokerage issued a buy rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and issued a $11.00 target price on shares of Kamada in a report on Thursday, May 9th. View […]